Cyprus

Cyprus has emerged as a dynamic hub for the global life sciences ecosystem, uniquely positioning itself as a strategic bridge between Europe, Asia and Africa.

The nation is best known for its robust pharmaceutical manufacturing sector, where high-quality generic drug production and specialized formulation development drive significant export growth.

Beyond traditional manufacturing, Cyprus is accelerating its footprint in biotechnology, fueled by the establishment of advanced biomanufacturing frameworks and state-of-the-art research centers like the Cyprus Institute of Neurology and Genetics.

The island’s healthcare innovation is supported by the comprehensive General Healthcare System (GeSY), which fosters a data-rich environment for clinical trial activity and personalized medicine.

In the medical device sector, the region is gaining recognition for integrating digital health solutions and bioinformatics to address chronic disease management.

Cyprus’s academic research excellence is anchored by top-tier institutions such as the University of Cyprus and European University Cyprus, both of which prioritize high-impact R&D and industry-academic partnerships.

Furthermore, the government’s focus on digital transformation and the European Health Data Space makes Cyprus an attractive destination for life sciences startups and venture capital.

With a highly skilled workforce and a favorable regulatory landscape, the country is transforming scientific excellence into tangible patient care outcomes. This multifaceted approach ensures that Cyprus remains a competitive leader in biomedical research and a vital node in the international pharma supply chain.